(Q43709293)

English

Alpha-interferon improves liver fibrosis in chronic hepatitis C: clinical significance of the serum N-terminal propeptide of procollagen type III.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Alpha-interferon improves liver fibrosis in chronic hepatitis C: clinical significance of the serum N-terminal propeptide of procollagen type III. (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

chronic hepatitis C

1 reference

based on heuristic

inferred from title

Fernando Ramalho

1 reference

ORCID Public Data File 2021

author name string

F Serejo

1

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

A Costa

2

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

A G Oliveira

3

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

F Ramalho

4

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

A Batista

5

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

M C De Moura

6

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

publication date

1 August 2001

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Digestive Diseases and Sciences

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

46

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

1684-1689

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

https://scigraph.springernature.com/pub.10.1023/a:1010649403659

0 references

Therapy of hepatitis C: overview

1 reference

https://pubmed.ncbi.nlm.nih.gov/11508668

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Connective tissue metabolism and hepatic fibrosis: an overview

1 reference

https://pubmed.ncbi.nlm.nih.gov/11508668

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular regulation of hepatic fibrogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/11508668

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatitis C: the clinical spectrum of disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/11508668

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapy of hepatitis C: interferon alfa-2a trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/11508668

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

alpha-Interferon in the treatment of chronic viral hepatitis: effects on fibrogenesis serum markers

1 reference

https://pubmed.ncbi.nlm.nih.gov/11508668

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Histological outcome in patients with chronic hepatitis C given a 60-week interferon alfa-2b treatment course

1 reference

https://pubmed.ncbi.nlm.nih.gov/11508668

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Basement membrane peptides as markers of liver disease in chronic hepatitis C

1 reference

https://pubmed.ncbi.nlm.nih.gov/11508668

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of liver histology, ALT elevation, and HCV RNA titer in patients with chronic hepatitis C.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11508668

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A histopathological study of the effects of 6-month versus 12-month interferon α-2b therapy in chronic hepatitis C

1 reference

https://pubmed.ncbi.nlm.nih.gov/11508668

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Classification of chronic viral hepatitis: a need for reassessment

1 reference

https://pubmed.ncbi.nlm.nih.gov/11508668

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/11508668

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term follow-up of serum N-terminal propeptide of collagen type III levels in patients with chronic liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/11508668

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cellular sources of collagen and regulation of collagen production in liver

1 reference

https://pubmed.ncbi.nlm.nih.gov/11508668

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of interferon treatment for patients with chronic hepatitis C: comparison of response in cirrhotics, fibrotics, or nonfibrotics

1 reference

https://pubmed.ncbi.nlm.nih.gov/11508668

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective inhibition of human diploid fibroblast collagen synthesis by interferons

1 reference

https://pubmed.ncbi.nlm.nih.gov/11508668

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum hyaluronan as a marker of liver fibrosis in chronic viral hepatitis C: effect of alpha-interferon therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/11508668

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

1 reference

https://pubmed.ncbi.nlm.nih.gov/11508668

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/11508668

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tissue inhibitor of metalloproteinase is increased in the serum of precirrhotic and cirrhotic alcoholic patients and can serve as a marker of fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/11508668

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of liver biopsy in hepatitis C.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11508668

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in serum fibrogenesis markers during interferon therapy for chronic hepatitis type C

1 reference

https://pubmed.ncbi.nlm.nih.gov/11508668

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Liver histology in hepatitis C infection: a comparison between patients with persistently normal or abnormal transaminases

1 reference

https://pubmed.ncbi.nlm.nih.gov/11508668

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Blood analysis for liver cirrhosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11508668

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term decrease in serum N-terminal propeptide of type III procollagen in patients with chronic hepatitis C treated with interferon alfa

1 reference

https://pubmed.ncbi.nlm.nih.gov/11508668

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum type III procollagen peptide, type IV collagen 7S domain, central triple-helix of type IV collagen and tissue inhibitor of metalloproteinases in patients with chronic viral liver disease: relationship to liver histology

1 reference

https://pubmed.ncbi.nlm.nih.gov/11508668

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is necroinflammation a prerequisite for fibrogenesis?

1 reference

https://pubmed.ncbi.nlm.nih.gov/11508668

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Matrix turnover in fibrogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/11508668

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced plasma transforming growth factor-beta1 levels in patients with chronic hepatitis C after interferon-alpha therapy: association with regression of hepatic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/11508668

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1023/A:1010649403659

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43709293&oldid=2102734071"